课题基金 / 基金详情

COVID 19-Scalable Production of Mechanically Resilient Biocidal Face Masks from Ultrafine Nonwoven Fibers

COVID 19-Scalable Production of Mechanically Resilient Biocidal Face Masks from Ultrafine Nonwoven Fibers
COVID 19——利用超细非织造纤维大规模生产机械弹性杀菌口罩
批准号:
550130-2020
负责人:
Park, Chul
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Park, Chul的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议是关于令人兴奋的可能性,使N95中的过滤材料-呼吸器和外科面罩-具有机械弹性,并能够变性传染性病原体,如细菌、病毒和真菌。 这项研究之所以重要,有几个原因。首先,口罩中发现的过滤材料通常是通过熔融吹塑工艺制成的。熔喷过滤器很脆弱,在变形(如拉伸)时容易损坏。如果我们能使这些过滤器在机械上坚固耐用,它们的寿命将会增加,因为它们不太可能被损坏。 其次,被捕获的病原体,如病毒、细菌和真菌,可以生活在这些过滤器的表面,以它们也捕获的有机营养为食。因此,这些过滤器常常成为病原体的“滋生地”。如果这些过滤器处理不当,它们可能是空气传播的次要来源。通过使这些过滤器显示出杀生活性,这些过滤器不仅可以捕获感染性病原体,还可以将它们完全灭活,从而消除二次传播的风险。 最后,人们对商用口罩中的高质量过滤材料的生产方法知之甚少。这是因为,工业规模生产这些过滤器所需的设计和工程原则被作为商业秘密保留在少数主导生产的公司手中。通过填补这一知识缺口,加拿大公司也将能够生产这些过滤器,减少我们对进口的依赖,以满足当地需求。这将改善加拿大的准备,以应对口罩需求的突然激增,以防再次爆发。此外,机械性能和杀生活性的提高将创造出比目前商业替代产品更具竞争力的优势。
英文摘要
This proposal is about the exciting possibility of making the filtration materials found in N95-respirators and surgical face masks mechanically resilient and able to denature infectious pathogens such as bacteria, viruses, and fungi. This research is important because of several reasons. First, the filtration materials found in masks are typically made via the process of melt blowing. Melt-blown filters are delicate and tend to get damaged when deformed (e.g. stretched). If we can make these filters mechanically robust, their lifespan will increase as they will be less likely to get damaged. Second, captured pathogens such as viruses, bacteria, and fungi, can live on the surface of these filters, feeding off of the organic nutrients also captured by them. As a result, these filters often become 'breeding grounds' for pathogens. If these filters are not disposed of properly, they can be a secondary source of airborne transmission. By making these filters exhibit biocidal activity, these filters will not only capture infectious pathogens but also deactivate them completely, eliminating this risk of secondary transmission. Finally, the method of producing high-quality filtration materials found in commercial face masks is poorly understood. This is because the design and engineering principles required to produce these filters at an industrial-scale are kept as trade-secrets within a handful of companies who dominate production. By filling this knowledge gap, Canadian companies will also be able to produce these filters, decreasing our reliance on imports to meet local demand. This will improve the preparedness of Canada to meet a sudden surge in demand for face masks in case of another outbreak. Furthermore, improvement in mechanical performance and biocidal activity will create competitive advantages over current commercial alternatives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanofibril Technology for advanced manufacturing of next generation of high performance plastic composites
  • 批准号:
    RGPIN-2020-06972
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2022
  • 负责人:
    Park, Chul
  • 依托单位:
NSERC/NanoXplore Industrial Research Chair in multi-functional graphene-based polymer nanocomposites and foams
  • 批准号:
    521714-2017
  • 项目类别:
    Industrial Research Chairs
  • 资助金额:
    $6.85万
  • 财政年份:
    2021
  • 负责人:
    Park, Chul
  • 依托单位:
Nanofibril Technology for advanced manufacturing of next generation of high performance plastic composites
  • 批准号:
    RGPIN-2020-06972
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2021
  • 负责人:
    Park, Chul
  • 依托单位:
Experimental investigation, modeling, and simulation of mold filling and cell structure development in foam injection molding
  • 批准号:
    528584-2018
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $6.87万
  • 财政年份:
    2020
  • 负责人:
    Park, Chul
  • 依托单位:
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: